All stories tagged :

Pr Newswire

Immuthera’s Scientific Advisory Board: World-Leading Expertise Driving Next-Generation Diabetes and Immunotherapy...

admin
Pr Newswire

ElmediX Plans Series A Round Based on Strong Signals in a...

admin
Pr Newswire

Jasper Therapeutics Presents Data from Preclinical Briquilimab Study at the 2024...

admin
Pr Newswire

Mineralys Therapeutics Appoints Biopharmaceutical Executive Alexander M. Gold, M.D. to its...

admin
Pr Newswire

ORYZON Presents Preliminary Data From Ongoing Phase Ib FRIDA Trial with...

admin
Pr Newswire

Findings on the Burdens of Diabetic Peripheral Neuropathic Pain (DPNP) Among...

admin
Pr Newswire

SLB and Aker Carbon Capture announce closing of carbon capture joint...

admin
Pr Newswire

Waydoo Flyer EVO: The Future of Efoiling

admin
Pr Newswire

THE HO CHI MINH CITY RIVER FESTIVAL 2024: UNFORGETTABLE AND INSPIRING...

admin
Pr Newswire

Bybit Web3 Celebrates 10 Million Wallet Milestones and Unveils Giveaways Worth...

admin
Pr Newswire

DobaShare Brings Excitement to Back-to-School Shopping with High-Commission Offers

admin

Featured

Pr Newswire

Virbac : Declaration of the number of shares and voting rights...

admin
Pr Newswire

Nxera Pharma to Receive US$4.8 Million in Milestone Payments Following Centessa’s...

admin
Pr Newswire

AB Science: Masitinib receives FDA and EMA authorization for confirmatory phase...

admin
Pr Newswire

Strüngmann Award Honors Araris Biotech Founding Team as 2025 Winner

admin
admin

Virbac : Declaration of the number of shares and voting rights...

DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital(Article 223-16 of the General regulations of the French Financial Market Authority – Autoritédes Marchés Financiers) Quotation place: Euronext ParisCompartiment AISIN code: FR0000031577 DateTotal...